Surgical menopause in patients with BRCA mutation, the role of hormone therapy
Introduction: Women with BRCA1/2 (mBRCA) mutation have an increased risk of developing breast (BC) and ovarian (OC) cancer. Bilateral salpingo-oophorectomy (BOS) is associated with an 80% risk reduction for OC and 50% for BC. The recommended age for this procedure is 35 to 40 years. The consequence...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Universitario Hospital Italiano de Buenos Aires
2023-09-01
|
Series: | Revista del Hospital Italiano de Buenos Aires |
Subjects: | |
Online Access: | https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/255/184 |